Journal of Immunology Research
Volume 2018 (2018), Article ID 4154507, 3 pages
https://doi.org/10.1155/2018/4154507

Corrigendum

Corrigendum to “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China”

Shang-Chen Yang,¹ Sindy Hu,1,2 Sheng-Zheng Zhang,¹ Jin-wen Huang,³ Jing Zhang,³ Chao Ji,³ and Bo Cheng³

¹Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, Fujian, China
²Department of Dermatology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
³Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

Correspondence should be addressed to Chao Ji; surpassing_ji@aliyun.com and Bo Cheng; chengbo630415@126.com

Received 13 May 2018; Accepted 29 May 2018; Published 28 June 2018

Copyright © 2018 Shang-Chen Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China” [1], there was an error in the value of the deceased patients, in the legend of Table 5, where “()” should be corrected to “().” The corrected table and its legend are shown below.

Table 5: Information of the deceased patients with SJS/TEN in this study ().

Phenotype
Sex
Age, y
Underlying disease
SCORTEN
Culprit drugs
Treatment

SJS
M
51
Chronic renal failure, diabetes
4
Allopurinol
Systemic steroids

TEN
M
70
Nil
6
Antibiotics
Systemic steroids

TEN
F
58
Aneurysm, subarachnoid hemorrhage
NA
Antibiotics
Systemic steroids

TEN
F
67
Rheumatic heart disease, mitral insufficiency
NA
Antibiotics and compound with aminopyrine, phenacetin, caffeine, phenobarbital
Systemic steroids with IVIG use in the late stage

TEN
F
71
Coronary heart disease, hypertension, diabetes, diabetic nephropathy
4
Calcium dobesilate
Systemic steroids with IVIG use in the early stage

TEN
M
62
Hypertension, diabetes
NA
Antibiotics
Systemic steroids with IVIG use in the early stage

TEN
M
94
Coronary heart disease, cardiac insufficiency, hypertension, diabetes, interstitial lung disease
NA
Antibiotics
Systemic steroids with IVIG use in the early stage

TEN
M
62
Hypertension, diabetes, chronic renal failure, hyperuricemia
NA
Allopurinol
Systemic steroids

TEN
M
3
Nil
2
Antibiotics
Systemic steroids

IVIG use in the early stage ≤ 7 days of onset, IVIG use in the late stage ≥ 7 days of onset. NA: not available.

References

S.-C. Yang, S. Hu, S.-Z. Zhang et al., “The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China,” Journal of Immunology Research, vol. 2018, Article ID 4320195, 10 pages, 2018.